Globus Medical, Inc. (GMED)

NYQ – Real vaqt narxi. Valyuta: USD

86.25

+1.60 (1.89%)

Yopilishda: Jun 26, 2026, 4:00 PM EDT

84.63

-1.62 (-1.88%)

Bozordan keyin: Jun 26, 2026, 6:40 PM EDT

15.06.2026

Here's How Innovation Fuels Globus Medical's Growth Momentum

GMED is accelerating product launches, FDA clearances and R&D investment, reinforcing its strategy to expand spine and orthopedic workflows.

09.06.2026

Here's How GMED Is Capitalizing on the Musculoskeletal Market Boom

Globus Medical is riding on musculoskeletal market growth with strong Q1 sales gains, double-digit spine growth, and rising trauma demand across key product lines.

08.06.2026

Does Globus Medical (GMED) Have the Potential to Rally 38.85% as Wall Street Analysts Expect?

The consensus price target hints at a 38.9% upside potential for Globus Medical (GMED). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

05.06.2026

GMED or PEN: Which Is the Better Value Stock Right Now?

Investors interested in stocks from the Medical - Instruments sector have probably already heard of Globus Medical (GMED) and Penumbra (PEN). But which of these two companies is the best option for those looking for undervalued stocks?

05.06.2026

Here's Why Globus Medical (GMED) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

04.06.2026

Here's How Financial Strength Remains a Key Advantage for GMED

Globus Medical's debt-free balance sheet, nearly $630M in liquid assets and strong cash flow give it the flexibility to fund growth and support shareholders.

02.06.2026

Should You Buy, Hold or Sell GMED Stock Amid Musculoskeletal Boom?

Globus Medical is riding musculoskeletal market growth with spine, trauma and ortho gains, strong cash flow and a debt-free balance sheet.

Videolar

No Data

There is no data to display

Press-relizlar

01.06.2026

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Globus Medical, Inc. (NYSE: GMED)

NEW YORK, June 1, 2026 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating Globus Medical, Inc. (NYSE: GMED) on behalf of the company's shareholders. The investigation seeks to determine whether Globus Medical's directors breached their fiduciary duties in connection with recent corporate actions.

07.05.2026

Globus Medical Reports First Quarter 2026 Results

AUDUBON, Pa., May 07, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced its financial results for the first quarter ended March 31, 2026.

23.03.2026

Globus Medical Announces Board Departure

AUDUBON, Pa., March 23, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced that John A. DeFord, PhD, a Director of Globus Medical Inc., notified the company of his decision to step down from the Board of Directors effective immediately and will not seek re-election at the Annual Meeting of Stockholders on June 3, 2026.

24.02.2026

Globus Medical Reports Fourth Quarter and Full Year 2025 Results

AUDUBON, Pa., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology solutions company, today announced its financial results for the fourth quarter and year ended December 31, 2025.

Globus Medical, Inc. (GMED)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Globus Medical, Inc. (GMED)

Here's How Innovation Fuels Globus Medical's Growth Momentum

Here's How GMED Is Capitalizing on the Musculoskeletal Market Boom

Does Globus Medical (GMED) Have the Potential to Rally 38.85% as Wall Street Analysts Expect?

GMED or PEN: Which Is the Better Value Stock Right Now?

Here's Why Globus Medical (GMED) is a Strong Value Stock

Here's How Financial Strength Remains a Key Advantage for GMED

Should You Buy, Hold or Sell GMED Stock Amid Musculoskeletal Boom?

Videolar

No Data

Press-relizlar

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Globus Medical, Inc. (NYSE: GMED)

Globus Medical Reports First Quarter 2026 Results

Globus Medical Announces Board Departure

Globus Medical Reports Fourth Quarter and Full Year 2025 Results

Here's How Innovation Fuels Globus Medical's Growth Momentum

Here's How GMED Is Capitalizing on the Musculoskeletal Market Boom

Does Globus Medical (GMED) Have the Potential to Rally 38.85% as Wall Street Analysts Expect?

GMED or PEN: Which Is the Better Value Stock Right Now?

Here's Why Globus Medical (GMED) is a Strong Value Stock

Here's How Financial Strength Remains a Key Advantage for GMED

Should You Buy, Hold or Sell GMED Stock Amid Musculoskeletal Boom?

Videolar

No Data

Press-relizlar

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Globus Medical, Inc. (NYSE: GMED)

Globus Medical Reports First Quarter 2026 Results

Globus Medical Announces Board Departure

Globus Medical Reports Fourth Quarter and Full Year 2025 Results

Search stocks

Globus Medical, Inc. (GMED)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Globus Medical, Inc. (GMED)

Here's How Innovation Fuels Globus Medical's Growth Momentum

Here's How GMED Is Capitalizing on the Musculoskeletal Market Boom

Does Globus Medical (GMED) Have the Potential to Rally 38.85% as Wall Street Analysts Expect?

GMED or PEN: Which Is the Better Value Stock Right Now?

Here's Why Globus Medical (GMED) is a Strong Value Stock

Here's How Financial Strength Remains a Key Advantage for GMED

Should You Buy, Hold or Sell GMED Stock Amid Musculoskeletal Boom?

Videolar

No Data

Press-relizlar

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Globus Medical, Inc. (NYSE: GMED)

Globus Medical Reports First Quarter 2026 Results

Globus Medical Announces Board Departure

Globus Medical Reports Fourth Quarter and Full Year 2025 Results

Here's How Innovation Fuels Globus Medical's Growth Momentum

Here's How GMED Is Capitalizing on the Musculoskeletal Market Boom

Does Globus Medical (GMED) Have the Potential to Rally 38.85% as Wall Street Analysts Expect?

GMED or PEN: Which Is the Better Value Stock Right Now?

Here's Why Globus Medical (GMED) is a Strong Value Stock

Here's How Financial Strength Remains a Key Advantage for GMED

Should You Buy, Hold or Sell GMED Stock Amid Musculoskeletal Boom?

Videolar

No Data

Press-relizlar

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Globus Medical, Inc. (NYSE: GMED)

Globus Medical Reports First Quarter 2026 Results

Globus Medical Announces Board Departure

Globus Medical Reports Fourth Quarter and Full Year 2025 Results